Epidemiological characterization of cutaneous malignant melanoma deaths in Brazil between 2020 and 2024

a cross-sectional study

Authors

Keywords:

Epidemiology, Cross-sectional studies, Melanoma, Mortality

Abstract

Cutaneous melanoma represents the most lethal subtype of skin cancer, standing out due to its high metastatic potential and its impact on mortality. This study aimed to characterize the epidemiological profile and temporal trends of cutaneous melanoma deaths in Brazil between 2020 and 2024. This was a cross-sectional, descriptive, retrospective, populationbased study using data from the Mortality Information System, including records classified under International Statistical Classification of Diseases and Related Health Problems code C43. During the study period, 9,792 deaths were recorded, showing relative temporal stability and the highest number of occurrences in 2023 (2,047 cases). Mortality was more frequent among males (57.34%), individuals aged 60 years or older (69.88%), White individuals (78.38%), and those with lower educational attainment (47.67%). The Southeast and South regions accounted for 75.37% of all deaths, although the North, Northeast, and Central-West regions exhibited more pronounced proportional increases throughout the historical series. A high frequency of records with unspecified anatomical location was also observed, highlighting limitations in the specificity of the available information. The findings demonstrate the persistence of disparities in melanoma mortality in Brazil and reinforce the need for targeted strategies focused on prevention, early diagnosis, and the strengthening of epidemiological surveillance, taking into account the sociodemographic and regional inequalities identified.

References

Brasil. Ministério da Saúde. Câncer de pele [Internet]. Brasília: Ministério da Saúde; [s.d.] [citado 2026 jun 9]. Disponível em: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/c/cancer-de-pele

PDQ Adult Treatment Editorial Board. Melanoma treatment (PDQ®): health professional version [Internet]. Bethesda (MD): National Cancer Institute (US); 2025 May 2 [citado 2026 jun 9]. Disponível em: https://www.cancer.gov/types/skin/hp/melanoma-treatment-pdq

Sukniam K, Manaise HK, Popp K, Popp R, Gabriel E. Role of surgery in metastatic melanoma and review of melanoma molecular characteristics. Cells. 2024;13(6):465. doi:10.3390/cells13060465.

Brasil. Instituto Nacional de Câncer. Câncer de pele melanoma [Internet]. Rio de Janeiro: INCA; 2022 [atualizado 2025 set 16; citado 2026 jun 9]. Disponível em: https://www.gov.br/inca/ pt-br/assuntos/cancer/tipos/pele-melanoma

Brasil. Ministério da Saúde. Sistema de Informação sobre Mortalidade: SIM [Internet]. Brasília: Ministério da Saúde; [s.d.] [citado 2026 jun 3]. Disponível em: Portal de Dados Abertos do SUS – SIM .

Silva MVP, Alencar JEFF, Abreu ISD, Lima AVC, Freitas Junior EA. Mortalidade por melanoma maligno no Brasil entre os anos de 2013 e 2022: tendências regionais, em relação ao gênero, etnia e à faixa etária. Scientia Generalis. 2024;5(1):111-121. doi:10.22289/sg.V5N1A11.

Melo AC, Wainstein AJA, Buzaid AC, Thuler LCS. Melanoma signature in Brazil: epidemiology, incidence, mortality, and trend lessons from a continental mixed population country in the past 15 years. Melanoma Res. 2018;28(6):629-636. doi:10.1097/CMR.0000000000000511.

Santos CA, Souza DLB. Melanoma mortality in Brazil: trends and projections (1998-2032). Cien Saude Colet. 2019;24(4):1551-1561. doi:10.1590/1413-81232018244.13932017. .

Barcaui CB, Machado CJ, Piñeiro-Maceira J. Impact of the SARS-CoV-2 pandemic on the diagnosis of primary cutaneous melanoma at a university hospital in Rio de Janeiro. An Bras Dermatol. 2022;97(6):801-803. doi:10.1016/j.abd.2022.04.001.

Silva Carvalho AC, Magalhães Ledsham Lopes C, Lobo AR, Assis IA, Medeiros HL, Drummond-Lage AP. Impact of the COVID-19 pandemic on the diagnosis and treatment of cutaneous melanoma in a public health service in Brazil. J Clin Aesthet Dermatol. 2025;18(4):E61-E65. PMID:40256343;

Iannacone MR, Green AC. Towards skin cancer prevention and early detection: evolution of skin cancer awareness campaigns in Australia. Melanoma Manag. 2014;1(1):75-84. doi:10.2217/mmt.14.6.

D’Ecclesiis O, Caini S, Martinoli C, Raimondi S, Gaiaschi C, Tosti G, Queirolo P, Veneri C, Saieva C, Gandini S, Chiocca S. Gender-dependent specificities in cutaneous melanoma predisposition, risk factors, somatic mutations, prognostic and predictive factors: a systematic review. Int J Environ Res Public Health. 2021;18(15):7945. doi:10.3390/ijerph18157945.

Gupta AK, Bharadwaj M, Mehrotra R. Skin cancer concerns in people of color: risk factors and prevention. Asian Pac J Cancer Prev. 2016;17(12):5257-5264. doi:10.22034/APJCP.2016.17.12.5257.

Instituto Brasileiro de Geografia e Estatística. Panorama do Censo 2022 [Internet]. Rio de Janeiro: IBGE; 2022 [citado 2026 jun 13]. Disponível em: Panorama do Censo 2022 – IBGE

Nogueira HR, Amorim EL, Genaro GD, Lourenço MCS, Dantas VHS, Sousa LVA. Disparities in time-to-treatment initiation and therapeutic modalities for malignant melanoma of the skin: a cross-sectional study, Brazil, 2013-2023. Epidemiol Serv Saude. 2026;35:e20250025. doi:10.1590/S2237-96222026v35e20250025.en.

Jiang AJ, Rambhatla PV, Eide MJ. Socioeconomic and lifestyle factors and melanoma: a systematic review. Br J Dermatol. 2015;172(4):885-915. doi:10.1111/bjd.13500.

Chang RC, Yen H, Heskett KM, Yen H. The role of health literacy in skin cancer preventative behavior and implications for intervention: a systematic review. J Prev. 2024;45(6):957- 972. doi:10.1007/s10935-024-00795-x.

Bello DM, Chou JF, Panageas KS, Brady MS, Coit DG, Carvajal RD, Ariyan CE. Prognosis of acral melanoma: a series of 281 patients. Ann Surg Oncol. 2013;20(11):3618-3625. doi:10.1245/s10434-013-3089-0.

Hoang MD, Bui TO, Dao VT, Le VQ, Lebbé C, Bousquet G. Genomics of primary and metastatic cutaneous melanoma: a systematic review and meta-analysis. Am J Clin Dermatol. 2026. doi:10.1007/s40257-026-01031-4.

Published

2026-11-12

How to Cite

1.
Naujorks Zimmer AL, Pacheco Rodrigues IL, Marques Rassi Tahan MV, de Faria Costa AC, Leite Magalhães Oliveira J, Melo Soares M. Epidemiological characterization of cutaneous malignant melanoma deaths in Brazil between 2020 and 2024: a cross-sectional study. Rev Goiana Med [Internet]. 2026 Nov. 12 [cited 2026 Nov. 15];68(72). Available from: https://amg.org.br/osj/index.php/RGM/article/view/748